Genetic mechanisms and aberrant gene expression during the development of gastric intestinal metaplasia and adenocarcinoma

Current Genomics

Volumn 8, Issue 6, 2007, Pages 379-397

  Holmes, K ^a   Egan, B ^a   Swan, N ^a   O'Morain, C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Aberrant gene expression; Gastric cancer; Genetic markers; Intestinal metaplasia

Indexed keywords

DNA; MICRORNA; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

CANCER MORTALITY; CANCER RISK; CHROMOSOMAL INSTABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MODEL; DNA METHYLATION; DNA MICROARRAY; GASTRITIS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC MARKER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE; REVIEW; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 41549090011     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920207783406460     Document Type: Review

References (145)

1. Kim, H. S., Lee, J. S., Freund, J. N., Min, K. W., Lee, J. S., Kim, W., Juhng, S. W. and Park, C. S. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. J. Gastroenterol. Hepatol. 2006, 21: 438-442.
2. Morson, B. C. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br. J. Cancer 1955, 9: 377-385.
3. Cunningham, S. C., Kamangar, F., Kim, M. P., Hammoud, S., Haque, R., Iacobuzio-Donahue, C. A., Maitra, A., Ashfaq, R., Hustinx, S., Heitmiller, R. E., Choti, M. A., Lillemoe, K. D., Cameron, J. L., Yeo, C. J., Schulick, R. D. and Montgomery, E. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol. Biomarkers Prev. 2006, 15: 281-287.
4. Matsukura, N., Kawachi, T., Sugimura, T., Nakadate, M. and Hirota, T. Induction of intestinal metaplasia and carcinoma in the glandular stomach of rats by N-alkyl-N'-nitro-N-nitrosoguanidines. Gann. 1979, 70: 181-185.
5. Sasajima, K., Kawachi, T., Matsukura, N., Sano, T. and Sugimura, T. Intestinal metaplasia and adenocarcinoma induced in the stomach of rats by N-propyl-N'-nitro-N-nitrosoguanidine. J. Cancer Res. Clin. Oncol. 1979, 94: 201-206.
6. Watanabe, H. Experimentally induced intestinal metaplasia in Wistar rats by X-ray irradiation. Gastroenterology 1978, 75: 796-799.
7. Yoshikawa, A., Inada Ki, K., Yamachika, T., Shimizu, N., Kaminishi, M. and Tatematsu, M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998, 1: 134-141.
8. Meireles, S. I., Cristo, E. B., Carvalho, A. F., Hirata, R., Jr., Pelosof, A., Gomes, L. I., Martins, W. K., Begnami, M. D., Zitron, C., Montagnini, A. L., Soares, F. A., Neves, E. J. and Reis, L. F. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res. 2004, 64: 1255-1265.
9. Sun, Y., Li, J. Y., He, J. S., Zhou, L. X. and Chen, K. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 2005, 46: 505-514.
10. Tamura, G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol. 2006, 12: 192-198.
11. Griffiths, E. A., Pritchard, S. A., Valentine, H. R., Whitchelo, N., Bishop, P. W., Ebert, M. P., Price, P. M., Welch, I. M. and West, C. M. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br. J. Cancer 2007, 96: 95-103.
12. Smith, M. G., Hold, G. L., Tahara, E. and El-Omar, E. M. Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 2006, 12: 2979-2990.
13. Correa, P. A human model of gastric carcinogenesis. Cancer Res. 1988, 48: 3554-3560.
14. Stemmermann, G. N. Intestinal metaplasia of the stomach. A status report. Cancer 1994, 74: 556-564.
15. Beswick, E. J., Bland, D. A., Suarez, G., Barrera, C. A., Fan, X. and Reyes, V. E. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect. Immun. 2005, 73: 2736-2743.
16. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52: 6735-6740.
17. Tahara, E. Genetic pathways of two types of gastric cancer. IARC Sci. Publ. 2004, 327-349.
18. Owen, D. Stomach. In: Histology for Pathologists (Ed S. S. Sternberg). 1997: pp. 491-492.
19. Tatematsu, M., Tsukamoto, T. and Inada, K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 2003, 94: 135-141.
20. Jass, J. R. and Filipe, M. I. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem. J. 1981, 13: 931-939.
21. Tsukamoto, T., Inada, K., Tanaka, H., Mizoshita, T., Mihara, M., Ushijima, T., Yamamura, Y., Nakamura, S. and Tatematsu, M. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J. Cancer Res. Clin. Oncol. 2004, 130: 135-145.
22. Dixon, M. F., Genta, R. M., Yardley, J. H. and Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996, 20: 1161-1181.
23. Almeida, R., Silva, E., Santos-Silva, F., Silberg, D. G., Wang, J., De Bolos, C. and David, L. Expression of inte stine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J. Pathol. 2003, 199: 36-40.
24. Tsukamoto, T., Mizoshita, T., Mihara, M., Tanaka, H., Takenaka, Y., Yamamura, Y., Nakamura, S., Ushijima, T. and Tatematsu, M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 2005, 46: 649-658.
25. Silberg, D. G., Sullivan, J., Kang, E., Swain, G. P., Moffett, J., Sund, N. J., Sackett, S. D. and Kaestner, K. H. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002, 122: 689-696.
26. Satoh, K., Mutoh, H., Eda, A., Yanaka, I., Osawa, H., Honda, S., Kawata, H., Kihira, K. and Sugano, K. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter. 2002, 7: 192-198.
27. Mesquita, P., Jonckheere, N., Almeida, R., Ducourouble, M. P., Serpa, J., Silva, E., Pigny, P., Silva, F. S., Reis, C., Silberg, D., Van Seuningen, I. and David, L. Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J. Biol. Chem. 2003, 278: 51549-51556.
28. Mutoh, H., Sakurai, S., Satoh, K., Tamada, K., Kita, H., Osawa, H., Tomiyama, T., Sato, Y., Yamamoto, H., Isoda, N., Yoshida, T., Ido, K. and Sugano, K. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res. 2004, 64: 7740-7747.
29. Mutoh, H., Sakurai, S., Satoh, K., Osawa, H., Hakamata, Y., Takeuchi, T. and Sugano, K. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004, 53: 1416-1423.
30. Guo, R. J., Sub, E. R. and Lynch, J. P. The role of Cdx proteins in intestinal development and cancer. Cancer Biol. Ther. 2004, 3: 593-601.
31. Gendron, F. P., Mongrain, S., Laprise, P., McMahon, S., Dubois, C. M., Blais, M., Asselin, C. and Rivard, N. The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290: G310-318.
32. Silva, E., Teixeira, A., David, L., Carneiro, F., Reis, C. A., Sobrinho-Simoes, J., Serpa, J., Veerman, E., Bolscher, J. and Sobrinho-Simoes, M. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch. 2002, 440: 311-317.
33. Sugai, T., Habano, W., Uesugi, N., Jao, Y. F., Nakamura, S., Abe, K., Takagane, A. and Terashima, M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers - a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod. Pathol. 2004, 17: 1223-1234.
34. Teixeira, A., David, L., Reis, C. A., Costa, J. and Sobrinho-Simoes, M. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J. Pathol. 2002, 197: 37-43.
35. Babu, S. D., Jayanthi, V., Devaraj, N., Reis, C. A. and Devaraj, H. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol. Cancer 2006, 5: 10.
36. Johnson, A. H., Frierson, H. F., Zaika, A., Powell, S. M., Roche, J., Crowe, S., Moskaluk, C. A. and El-Rifai, W. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am. J. Pathol. 2005, 167: 577-584.
37. Dong, W., Yu, Q. and Xu, Y. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig. Dis. Sci. 2007, 52: 536-542.
38. Almeida, R., Almeida, J., Shoshkes, M., Mendes, N., Mesquita, P., Silva, E., Van Seuningen, I., Reis, C. A., Santos-Silva, F. and David, L. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J. Pathol. 2005, 207: 396-401.
39. El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F., Jr. and Rabkin, C. S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404: 398-402.
40. Macarthur, M., Hold, G. L. and El-Omar, E. M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286: G515-520.
41. El-Omar, E. M., Rabkin, C. S., Gammon, M. D., Vaughan, T. L., Risch, H. A., Schoenberg, J. B., Stanford, J. L., Mayne, S. T., Goedert, J., Blot, W. J., Fraumeni, J. F., Jr. and Chow, W. H. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124: 1193-1201.
42. Rad, R., Dossumbekova, A., Neu, B., Lang, R., Bauer, S., Saur, D., Gerhard, M. and Prinz, C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004, 53: 1082-1089.
43. Gologan, A., Graham, D. Y. and Sepulveda, A. R. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin. Lab. Med. 2005, 25: 197-222.
44. Hou, L., El-Omar, E. M., Chen, J., Grillo, P., Rabkin, C. S., Baccarelli, A., Yeager, M., Chanock, S. J., Zatonski, W., Sobin, L. H., Lissowska, J., Fraumeni, J. F., Jr. and Chow, W. H. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007, 28: 118-123.
45. Lochhead, P. and El-Omar, E. M. Helicobacter pylori infection and gastric cancer. Best Pract. Res. Clin. Gastroenterol. 2007, 21: 281-297.
46. You, W. C., Hong, J. Y., Zhang, L., Pan, K. F., Pee, D., Li, J. Y., Ma, J. L., Rothman, N., Caporaso, N., Fraumeni, J. F., Jr., Xu, G. W. and Gail, M. H. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2005, 14: 451-458.
47. Stock, M. and Otto, F. Gene deregulation in gastric cancer. Gene 2005, 360: 1-19.
48. Oue, N., Mitani, Y., Motoshita, J., Matsumura, S., Yoshida, K., Kuniyasu, H., Nakayama, H. and Yasui, W. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 2006, 106: 1250-1259.
49. Kent, O. A. and Mendell, J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25: 6188-6196.
50. Zhang, B., Pan, X., Cobb, G. P. and Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302: 1-12.
51. Isogaki, J., Shinmura, K., Yin, W., Arai, T., Koda, K., Kimura, T., Kino, I. and Sugimura, H. Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. Cancer Detect. Prev. 1999, 23: 204-214.
52. Watari, J., Tanaka, A., Tanabe, H., Sato, R., Moriichi, K., Zaky, A. H., Okamoto, K., Maemoto, A., Fujiya, M., Ashida, T., Das, K. M. and Kohgo, Y. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: A comparison before and after eradication in patients with chronic gastritis and gastric cancer. J. Clin. Pathol. 2006.
53. Varis, A., Wolf, M., Monni, O., Vakkari, M. L., Kokkola, A., Moskaluk, C., Frierson, H., Jr., Powell, S. M., Knuutila, S., Kallioniemi, A. and El-Rifai, W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 2002, 62: 2625-2629.
54. Leung, S. Y., Ho, C., Tu, I. P., Li, R., So, S., Chu, K. M., Yuen, S. T. and Chen, X. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod. Pathol. 2006, 19: 854-863.
55. Calcagno, D. Q., Leal, M. F., Seabra, A. D., Khayat, A. S., Chen, E. S., Demachki, S., Assumpcao, P. P., Faria, M. H., Rabenhorst, S. H., Ferreira, M. V., de Arruda Cardoso Smith, M. and Burbano, R. R. Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J. Gastroenterol. 2006, 12: 6207-6211.
56. Burbano, R. R., Assumpcao, P. P., Leal, M. F., Calcagno, D. Q., Guimaraes, A. C., Khayat, A. S., Takeno, S. S., Chen, E. S. and De Arruda Cardoso Smith, M. C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res. 2006, 26: 2909-2914.
57. Bagnyukova, T. V., Pogribny, I. P. and Chekhun, V. F. MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Exp. Oncol. 2006, 28: 263-269.
58. Wu, W., Sun, M., Zou, G. M. and Chen, J. MicroRNA and cancer: Current status and prospective. Int. J. Cancer 2007, 120: 953-960.
59. Esquela-Kerscher, A. and Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6: 259-269.
60. Jovanovic, M. and Hengartner, M. O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25: 6176-6187.
61. He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J. and Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature 2005, 435: 828-833.
62. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. and Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435: 839-843.
63. Tenderenda, M. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes. J. Exp. Clin. Cancer Res. 2005, 24: 405-414.
64. Aoyagi, K., Koufuji, K., Yano, S., Murakami, N., Terasaki, Y., Yamasaki, Y., Takeda, J., Tanaka, M. and Shirouzu, K. Immuno-histochemical study on the expression of cyclin D1 and E in gastric cancer. Kurume Med. J. 2000, 47: 199-203.
65. Song, J. H., Kim, C. J., Cho, Y. G., Park, Y. K., Nam, S. W., Yoo, N. J., Lee, J. Y. and Park, W. S. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients. Neoplasma 2007, 54: 235-239.
66. Gao, P., Zhou, G. Y., Liu, Y., Li, J. S., Zhen, J. H. and Yuan, Y. P. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J. Gastroenterol. 2004, 10: 2936-2939.
67. Kim, J. M., Sohn, H. Y., Yoon, S. Y., Oh, J. H., Yang, J. O., Kim, J. H., Song, K. S., Rho, S. M., Yoo, H. S., Kim, Y. S., Kim, J. G. and Kim, N. S. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin. Cancer Res. 2005, 11: 473-482.
68. Peng, Z., Wei, D., Wang, L., Tang, H., Zhang, J., Le, X., Jia, Z., Li, Q. and Xie, K. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Clin. Cancer Res. 2006, 12: 6386-6394.
69. Wang, T. B., Deng, M. H., Qiu, W. S. and Dong, W. G. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J. Gastroenterol. 2007, 13: 1794-1798.
70. El-Rifai, W., Frierson, H. F., Jr., Harper, J. C., Powell, S. M. and Knuutila, S. Expression profiling of gastric adenocarcinoma using cDNA array. Int. J. Cancer 2001, 92: 832-838.
71. Shaoul, R., Eliahu, L., Sher, I., Hamlet, Y., Miselevich, I., Goldshmidt, O. and Ron, D. Elevated expression of FGF7 protein is common in human gastric diseases. Biochem. Biophys. Res. Commun. 2006, 350: 825-833.
72. Egeblad, M. and Werb, Z. New functions for the matrix metallo-proteinases in cancer progression. Nat. Rev. Cancer 2002, 2: 161-174.
73. Handsley, M. M. and Edwards, D. R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 2005, 115: 849-860.
74. Hippo, Y., Taniguchi, H., Tsutsumi, S., Machida, N., Chong, J. M., Fukayama, M., Kodama, T. and Aburatani, H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 62: 233-240.
75. Tay, S. T., Leong, S. H., Yu, K., Aggarwal, A., Tan, S. Y., Lee, C. H., Wong, K., Visvanathan, J., Lim, D., Wong, W. K., Soo, K. C., Kon, O. L. and Tan, P. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res. 2003, 63: 3309-3316.
76. Takaishi, S. and Wang, T. C. Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Sci. 2007, 98: 284-293.
77. Ogasawara, N., Tsukamoto, T., Mizoshita, T., Inada, K., Cao, X., Takenaka, Y., Joh, T. and Tatematsu, M. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 2006, 49: 612-621.
78. Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Akiyama, T., Peek, R. M., Jr., Azuma, T. and Hatakeyama, M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007.
79. Song, J., Xie, H., Lian, Z., Yang, G., Du, R., Du, Y., Zou, X., Jin, H., Gao, J., Liu, J. and Fan, D. Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia 2006, 8: 995-1002.
80. Nishigaki, M., Aoyagi, K., Danjoh, I., Fukaya, M., Yanagihara, K., Sakamoto, H., Yoshida, T. and Sasaki, H. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 2005, 65: 2115-2124.
81. Wang, J., Yang, Y., Xia, H. H., Gu, Q., Lin, M. C., Jiang, B., Peng, Y., Li, G., An, X., Zhang, Y., Zhuang, Z., Zhang, Z., Kung, H. F. and Wong, B. C. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 2007, 132: 1066-1076.
82. Wang, H., Zhao, L. N., Li, K. Z., Ling, R., Li, X. J. and Wang, L. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer 2006, 6: 91.
83. Clements, W. M., Wang, J., Sarnaik, A., Kim, O. J., MacDonald, J., Fenoglio-Preiser, C., Groden, J. and Lowy, A. M. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002, 62: 3503-3506.
84. Dvory-Sobol, H., Sagiv, E., Liberman, E., Kazanov, D. and Arber, N. Suppression of gastric cancer cell growth by targeting the beta-catenin/ T-cell factor pathway. Cancer 2007, 109: 188-197.
85. Byun, T., Karimi, M., Marsh, J. L., Milovanovic, T., Lin, F. and Holcombe, R. F. Expression of secreted Wnt antagonists in gastro-intestinal tissues: potential role in stem cell homeostasis. J. Clin. Pathol. 2005, 58: 515-519.
86. Nojima, M., Suzuki, H., Toyota, M., Watanabe, Y., Maruyama, R., Sasaki, S., Sasaki, Y., Mita, H., Nishikawa, N., Yamaguchi, K., Hirata, K., Itoh, F., Tokino, T., Mori, M., Imai, K. and Shinomura, Y. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 2007.
87. Zhao, C. H., Bu, X. M. and Zhang, N. Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer. World J. Gastroenterol. 2007, 13: 2214-2217.
88. Weisz, L., Oren, M. and Rotter, V. Transcription regulation by mutant p53. Oncogene 2007, 26: 2202-2211.
89. Ranzani, G. N., Luinetti, O., Padovan, L. S., Calistri, D., Renault, B., Burrel, M., Amadori, D., Fiocca, R. and Solcia, E. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol. Biomarkers Prev. 1995, 4: 223-231.
90. Ozaki, T. and Nakagawara, A. p73, a sophisticated p53 family member in the cancer world. Cancer Sci. 2005, 96: 729-737.
91. Marabese, M., Vikhanskaya, F. and Broggini, M. p73: A chiaroscuro gene in cancer. Eur. J. Cancer 2007.
92. Yoo, N. J., Lee, J. W., Jeong, E. G. and Lee, S. H. Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas. Dig Liver Dis. 2007, 39: 222-227.
93. Bae, S. C. and Choi, J. K. Tumor suppressor activity of RUNX3. Oncogene 2004, 23: 4336-4340.
94. Kim, T. Y., Lee, H. J., Hwang, K. S., Lee, M., Kim, J. W., Bang, Y. J. and Kang, G. H. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest. 2004, 84: 479-484.
95. Iida, S., Akiyama, Y., Nakajima, T., Ichikawa, W., Nihei, Z., Sugihara, K. and Yuasa, Y. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer. Int. J. Cancer 2000, 87: 654-658.
96. Esteller, M., Cordon-Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capella, G., Peinado, M. A., Matias-Guiu, X., Prat, J., Baylin, S. B. and Herman, J. G. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res. 2001, 61: 2816-2821.
97. To, K. F., Leung, W. K., Lee, T. L., Yu, J., Tong, J. H., Chan, M. W., Ng, E. K., Chung, S. C. and Sung, J. J. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int. J. Cancer 2002, 102: 623-628.
98. Kim, H., Kim, Y. H., Kim, S. E., Kim, N. G., Noh, S. H. and Kim, H. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J. Pathol. 2003, 200: 23-31.
99. Luo, D., Zhang, B., Lv, L., Xiang, S., Liu, Y., Ji, J. and Deng, D. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab. Invest. 2006, 86: 591-598.
100. Min, K. O., Seo, E. J., Kwon, H. J., Lee, E. J., Kim, W. I., Kang, C. S. and Kim, K. M. Methylation of p16(INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas. Mod. Pathol. 2006, 19: 141-148.
101. Kang, G. H., Shinn, Y. H., Jung, H. Y., Kim, W. H., Ro, J. Y. and Rhyu, M. G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001, 61: 2847-2851.
102. Kang, G. H., Lee, H. J., Hwang, K. S., Lee, S., Kim, J. H. and Kim, J. S. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am. J. Pathol. 2003, 163: 1551-1556.
103. Lee, J. H., Park, S. J., Abraham, S. C., Seo, J. S., Nam, J. H., Choi, C., Juhng, S. W., Rashid, A., Hamilton, S. R. and Wu, T. T. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004, 23: 4646-4654.
104. Doganavsargil, B., Sarsik, B., Kirdok, F. S., Musoglu, A. and Tuncyurek, M. p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids). World J. Gastroenterol. 2006, 12: 6280-6284.
105. Li, X., Zhang, Y. Y., Wang, Q. and Fu, S. B. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells. World J. Gastroenterol. 2005, 11: 61-68.
106. Lee, Y. S. and Dutta, A. MicroRNAs: small but potent oncogenes or tumor suppressors. Curr. Opin. Investig. Drugs 2006, 7: 560-564.
107. Sawabu, T., Seno, H., Kawashima, T., Fukuda, A., Uenoyama, Y., Kawada, M., Kanda, N., Sekikawa, A., Fukui, H., Yanagita, M., Yoshibayashi, H., Satoh, S., Sakai, Y., Nakano, T. and Chiba, T. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol. Carcinog. 2007, 46: 155-164.
108. Murakami, D., Tsujitani, S., Osaki, T., Saito, H., Katano, K., Tatebe, S. and Ikeguchi, M. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy. Gastric Cancer 2007, 10: 45-51.
109. Kwon, M. J. and Nam, T. J. A polysaccharide of the marine alga Capsosiphon fulvescens induces apoptosis in AGS gastric cancer cells via an IGF-IR-mediated PI3K/Akt pathway. Cell Biol. Int. 2007.
110. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991, 51: 3075-3079.
111. Hackett, J. A., Feldser, D. M. and Greider, C. W. Telomere dysfunction increases mutation rate and genomic instability. Cell 2001, 106: 275-286.
112. Jung, H. Y., Jung, K. C., Shim, Y. H., Ro, J. Y. and Kang, G. H. Methylation of the hMLH1 promoter in multiple gastric carcinomas with microsatellite instability. Pathol. Int. 2001, 51: 445-451.
113. Fleisher, A. S., Esteller, M., Tamura, G., Rashid, A., Stine, O. C., Yin, J., Zou, T. T., Abraham, J. M., Kong, D., Nishizuka, S., James, S. P., Wilson, K. T., Herman, J. G. and Meltzer, S. J. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 2001, 20: 329-335.
114. Fang, D. C., Yang, S. M., Zhou, X. D., Wang, D. X. and Luo, Y. H. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J. Gastroenterol. 2001, 7: 522-526.
115. Kondo, T., Oue, N., Yoshida, K., Mitani, Y., Naka, K., Nakayama, H. and Yasui, W. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res. 2004, 64: 523-529.
116. Sato, F. and Meltzer, S. J. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006, 106: 483-493.
117. Kang, G. H., Lee, S., Shim, Y. H., Kim, J. C. and Ro, J. Y. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Pathol. Int. 2002, 52: 764-768.
118. Jones, P. A. and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3: 415-428.
119. Wu, M., Semba, S., Oue, N., Ikehara, N., Yasui, W. and Yokozaki, H. BRAF/ K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 2004, 7: 246-253.
120. Ushijima, T., Nakajima, T. and Maekita, T. DNA methylation as a marker for the past and future. J. Gastroenterol. 2006, 41: 401-407.
121. Maekita, T., Nakazawa, K., Mihara, M., Nakajima, T., Yanaoka, K., Iguchi, M., Arii, K., Kaneda, A., Tsukamoto, T., Tatematsu, M., Tamura, G., Saito, D., Sugimura, T., Ichinose, M. and Ushijima, T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006, 12: 989-995.
122. Weiss, M. M., Kuipers, E. J., Postma, C., Snijders, A. M., Stolle, M., Vieth, M., Pinkel, D., Meuwissen, S. G., Albertson, D. and Meijer, G. A. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol. Pathol. 2003, 56: 293-298.
123. Takenawa, H., Kurosaki, M., Enomoto, N., Miyasaka, Y., Kanazawa, N., Sakamoto, N., Ikeda, T., Izumi, N., Sato, C. and Watanabe, M. Differential gene-expression profiles associated with gastric adenoma. Br. J. Cancer 2004, 90: 216-223.
124. Friis-Hansen, L., Rieneck, K., Nilsson, H. O., Wadstrom, T. and Rehfeld, J. F. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology 2006, 131: 246-258.
125. Boussioutas, A., Li, H., Liu, J., Waring, P., Lade, S., Holloway, A. J., Taupin, D., Gorringe, K., Haviv, I., Desmond, P. V. and Bowtell, D. D. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 2003, 63: 2569-2577.
126. Chang, Y., Gong, J., Liu, B., Zhang, J. and Dai, F. Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray. World J. Gastroenterol. 2004, 10: 3194-3196.
127. Gomes, L. I., Esteves, G. H., Carvalho, A. F., Cristo, E. B., Hirata, R., Jr., Martins, W. K., Marques, S. M., Camargo, L. P., Brentani, H., Pelosof, A., Zitron, C., Sallum, R. A., Montagnini, A., Soares, F. A., Neves, E. J. and Reis, L. F. Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism. Cancer Res. 2005, 65: 7127-7136.
128. Fitzgerald, R. C. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2006, 55: 1810-1820.
129. Hao, Y., Triadafilopoulos, G., Sahbaie, P., Young, H. S., Omary, M. B. and Lowe, A. W. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 2006, 131: 925-933.
130. Ostrowski, J., Rubel, T., Wyrwicz, L. S., Mikula, M., Bielasik, A., Butruk, E. and Regula, J. Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures. J. Mol. Med. 2006, 84: 872-882.
131. Greenawalt, D. M., Duong, C., Smyth, G. K., Ciavarella, M. L., Thompson, N. J., Tiang, T., Murray, W. K., Thomas, R. J. and Phillips, W. A. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma. Int. J. Cancer 2007, 120: 1914-1921.
132. Maley, C. C. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett. 2007, 245: 22-32.
133. Lynch, H. T., Grady, W., Suriano, G. and Huntsman, D. Gastric cancer: new genetic developments. J. Surg. Oncol. 2005, 90: 114-133; discussion 133.
134. Oliveira, C., Seruca, R. and Carneiro, F. Genetics, pathology, and clinics of familial gastric cancer. Int. J. Surg. Pathol. 2006, 14: 21-33.
135. Milne, A. N., Sitarz, R., Carvalho, R., Carneiro, F. and Offerhaus, G. J. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr. Mol. Med. 2007, 7: 15-28.
136. Hasegawa, S., Furukawa, Y., Li, M., Satoh, S., Kato, T., Watanabe, T., Katagiri, T., Tsunoda, T., Yamaoka, Y. and Nakamura, Y. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res. 2002, 62: 7012-7017.
137. Jinawath, N., Furukawa, Y., Hasegawa, S., Li, M., Tsunoda, T., Satoh, S., Yamaguchi, T., Imamura, H., Inoue, M., Shiozaki, H. and Nakamura, Y. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004, 23: 6830-6844.
138. Yu, C. D., Xu, S. H., Mou, H. Z., Jiang, Z. M., Zhu, C. H. and Liu, X. L. Gene expression profile differences in gastric cancer, peri-cancerous epithelium and normal gastric mucosa by gene chip. World J. Gastroenterol. 2005, 11: 2390-2397.
139. Oue, N., Hamai, Y., Milani, Y., Matsumura, S., Oshimo, Y., Aung, P. P., Kuraoka, K., Nakayama, H. and Yasui, W. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004, 64: 2397-2405.
140. Sekikawa, A., Fukui, H., Fujii, S., Takeda, J., Nanakin, A., Hisatsune, H., Seno, H., Takasawa, S., Okamoto, H., Fujimori, T. and Chiba, T. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 2005, 128: 642-653.
141. Akagi, M., Yokozaki, H., Kitadai, Y., Ito, R., Yasui, W., Haruma, K., Kajiyama, G. and Tahara, E. Expression of amphiregulin in human gastric cancer cell lines. Cancer 1995, 75: 1460-1466.
142. Yap, Y. L., Zhang, X. W., Smith, D., Soong, R. and Hill, J. Molecular gene expression signature patterns for gastric cancer diagnosis. Comput. Biol. Chem. 2007.
143. Wang, L., Zhu, J. S., Song, M. Q., Chen, G. Q. and Chen, J. L. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser micro-dissection and cDNA microarray. World J. Gastroenterol. 2006, 12: 6949-6954.
144. Trautmann, K., Steudel, C., Grossmann, D., Aust, D., Ehninger, G., Miehlke, S. and Thiede, C. Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability. World J. Gastroenterol. 2005, 11: 5993-5996.
145. de Vries, A. C., Haringsma, J. and Kuipers, E. J. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007, 12: 1-15.